ScinoPharm Taiwan, Ltd. (TPE:1789)
Taiwan · Delayed Price · Currency is TWD 18.85
+0.95 (5.31%)
Sep 10, 2025, 1:35 PM CST
ScinoPharm Taiwan Market Cap
ScinoPharm Taiwan has a market cap or net worth of 14.15 billion as of September 9, 2025. Its market cap has decreased by -29.94% in one year.
Market Cap
14.15B
Enterprise Value
11.79B
Revenue
3.19B
Ranking
n/a
PE Ratio
69.16
Stock Price
18.85
Market Cap Chart
Since October 29, 2010, ScinoPharm Taiwan's market cap has decreased from 30.44B to 14.15B, a decrease of -53.49%. That is a compound annual growth rate of -5.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2025 | 14.15B | -18.82% |
| Dec 31, 2024 | 17.44B | -16.48% |
| Dec 29, 2023 | 20.88B | 3.73% |
| Dec 30, 2022 | 20.12B | 3.25% |
| Dec 30, 2021 | 19.49B | -14.56% |
| Dec 31, 2020 | 22.81B | 8.46% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 395.51B |
| PharmaEssentia | 169.97B |
| Bora Pharmaceuticals Co., LTD. | 90.84B |
| Lotus Pharmaceutical | 50.62B |
| Lumosa Therapeutics | 40.77B |
| Oneness Biotech | 36.44B |
| Polaris Group | 29.47B |
| Center Laboratories | 28.63B |